| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 6.327 | 31.180 | 41.828 | 34.736 |
| Total Income - EUR | - | - | - | - | - | 0 | 6.327 | 31.180 | 41.828 | 34.736 |
| Total Expenses - EUR | - | - | - | - | - | 1.270 | 13.022 | 32.174 | 41.419 | 40.449 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.270 | -6.695 | -994 | 409 | -5.713 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.270 | -6.713 | -1.812 | 282 | -5.713 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Pharmaweb Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 2.751 | 2.383 | 982 | 691 | 320 |
| Current Assets | - | - | - | - | - | 791 | 16.422 | 17.419 | 17.839 | 12.426 |
| Inventories | - | - | - | - | - | 320 | 15.722 | 15.566 | 15.646 | 10.421 |
| Receivables | - | - | - | - | - | 0 | 338 | 756 | 906 | 1.476 |
| Cash | - | - | - | - | - | 471 | 362 | 1.097 | 1.287 | 529 |
| Shareholders Funds | - | - | - | - | - | -1.187 | -7.874 | -9.711 | -9.399 | -15.060 |
| Social Capital | - | - | - | - | - | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | 4.729 | 26.679 | 28.112 | 27.930 | 27.806 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharmaweb Srl